Clarus Therapeutics
Oral Testosterone Replacement Therapy.
Launch date
Employees
Market cap
-
Enterprise valuation
€345m (Public information from Apr 2021)
Northbrook Illinois (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$2.5m | Series A | ||
N/A | Series B | ||
$8.0m | Series C | ||
$10.0m | Debt | ||
$31.5m | Late VC | ||
$50.0m Valuation: $379m | SPAC IPO | ||
$25.0m Valuation: $379m | SPAC Private Placement | ||
| Total Funding | €60.9m | ||
Related Content
Recent News about Clarus Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.